Dazert P, Suofu Y, Grube M, Popa-Wagner A, Kroemer H K, Jedlitschky G, Kessler C
Department of Pharmacology, Research Center of Pharmacology and Experimental Therapeutics, Ernst-Moritz-Arndt University, Greifswald, Germany.
Neuroscience. 2006 Nov 3;142(4):1071-9. doi: 10.1016/j.neuroscience.2006.07.056. Epub 2006 Sep 25.
Members of various transport protein families including ATP-binding cassette transporters and solute carriers were shown to be expressed in brain capillaries, choroid plexus, astrocytes or neurons, controlling drug and metabolite distribution to and from the brain. However, data are currently very limited on how the expression of these transport systems is affected by damage to the brain such as stroke. Therefore we studied the expression of four selected transporters, P-glycoprotein (Mdr1a/b; Abcb1a/b), Mrp5 (Abcc5), Bcrp (Abcg2), and Oatp2 (Slc21a5) in a rat model for stroke. Transporter expression was analyzed by real-time polymerase chain reaction in the periinfarcted region and protein localization and cellular phenotyping were done by immunohistochemistry and confocal immunofluorescence microscopy. After stroke, P-glycoprotein staining was detected in endothelial cells of disintegrated capillaries and by day 14 in newly generated blood vessels. There was no significant difference, however, in the Mdr1a mRNA amount in the periinfarcted region compared with the contralateral site. For Bcrp, a significant mRNA up-regulation was observed from days 3-14. This up-regulation was followed by the protein as confirmed by quantitative immunohistochemistry. Oatp2, located in the vascular endothelium, was also up-regulated at day 14. For Mrp5, an up-regulation was observed in neurons in the periinfarcted region (day 14). In conclusion, after stroke the transport proteins were up-regulated with a maximum at day 14, a time point that coincides with behavioral recuperation. The study further suggests Bcrp as a pronounced marker for the regenerative process and a possible functional role of Mrp5 in surviving neurons.
包括ATP结合盒转运体和溶质载体在内的各种转运蛋白家族成员已被证明在脑毛细血管、脉络丛、星形胶质细胞或神经元中表达,控制药物和代谢物进出大脑的分布。然而,目前关于这些转运系统的表达如何受到中风等脑损伤影响的数据非常有限。因此,我们在大鼠中风模型中研究了四种选定转运体的表达,即P-糖蛋白(Mdr1a/b;Abcb1a/b)、Mrp5(Abcc5)、Bcrp(Abcg2)和Oatp2(Slc21a5)。通过实时聚合酶链反应分析梗死周边区域的转运体表达,并通过免疫组织化学和共聚焦免疫荧光显微镜进行蛋白定位和细胞表型分析。中风后,在崩解毛细血管的内皮细胞中检测到P-糖蛋白染色,到第14天在新生血管中也能检测到。然而,梗死周边区域的Mdr1a mRNA量与对侧部位相比没有显著差异。对于Bcrp,在第3 - 14天观察到mRNA显著上调。定量免疫组织化学证实这种上调随后出现蛋白表达上调。位于血管内皮的Oatp2在第14天也上调。对于Mrp5,在梗死周边区域的神经元中观察到上调(第14天)。总之,中风后转运蛋白上调,在第14天达到最大值,这与行为恢复的时间点一致。该研究进一步表明Bcrp是再生过程的显著标志物,以及Mrp5在存活神经元中可能具有的功能作用。